Research

Medical Sciences

Title :

Harnessing therapeutic potential of novel Spisulosine derivative as robust autophagy inducer against Triple Negative Breast Cancer (TNBC) in-vitro & in-vivo

Area of research :

Medical Sciences

Focus area :

Ad-hoc, ADHOC

Principal Investigator :

Dr. D. Datta, CSIR-Central Drug Research Institute, Uttar Pradesh

Timeline Start Year :

2019

Timeline End Year :

2022

Details

Total Budget (INR):

16,60,000

Organizations involved